{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T10:20:14Z","timestamp":1769077214779,"version":"3.49.0"},"reference-count":27,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2004,3,4]],"date-time":"2004-03-04T00:00:00Z","timestamp":1078358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2004,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>The objective of the current study was to evaluate the efficacy of intensive chemotherapy with and without cranial radiation for central nervous system (CNS) prophylaxis in adults with Burkitt leukemia or lymphoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Patients received 18 weeks of therapy. Prophylactic cranial radiation (2400 centigrays) and 12 doses of triple intrathecal chemotherapy were administered to the first cohort of patients. A subsequent cohort received the same therapy, with the exceptions that intrathecal therapy was reduced to six doses and radiotherapy was administered only to high\u2010risk individuals.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>The median follow\u2010up durations were 6.8 years in Cohort 1 and 4.1 years in Cohort 2. Three occurrences of transverse myelitis, 2 severe neuropathies, 3 cases of aphasia, and 1 case of blindness were documented in the first cohort of 52 patients (Cohort 1). In the subsequent cohort of 40 patients (Cohort 2), none of these occurrences were observed, and patients experienced less neurologic toxicity overall (61% vs. 26%; <jats:italic>P<\/jats:italic> = 0.001). Responses were similar, and the 3\u2010year event\u2010free survival rate was 0.52 (95% confidence interval, 0.38\u20130.65) for Cohort 1 and 0.45 (0.29\u20130.60) for Cohort 2.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Intensive, short\u2010duration chemotherapy with less intensive CNS prophylaxis led to control at this sanctuary site with little neurotoxicity and may be curative for adults with Burkitt leukemia or lymphoma. Cancer 2004;100:1438\u201348. \u00a92004 by the American Cancer Society.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.20143","type":"journal-article","created":{"date-parts":[[2004,3,23]],"date-time":"2004-03-23T08:40:57Z","timestamp":1080031257000},"page":"1438-1448","source":"Crossref","is-referenced-by-count":80,"title":["Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma"],"prefix":"10.1002","volume":"100","author":[{"given":"David A.","family":"Rizzieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Niedzwiecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Vardiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayard L.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Barcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara D.","family":"Bloomfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce A.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George P.","family":"Canellos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,3,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-12-939"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830380107"},{"key":"e_1_2_6_5_2","first-page":"181","volume-title":"World Health Organization classification of tumours Pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"Diebold J","year":"2001"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.1.123"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V85.3.664.bloodjournal853664","article-title":"Small non\u2010cleaved cell leukemia and lymphoma in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols","volume":"85","author":"Soussain C","year":"1995","journal-title":"Blood."},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","article-title":"Improved outcome in adult B cell acute lymphoblastic leukemia","volume":"87","author":"Hoelzer D","year":"1996","journal-title":"Blood."},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.20.4014"},{"key":"e_1_2_6_10_2","volume-title":"The statistical analysis of failure time data","author":"Kalbfleisch J","year":"1980"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.12.1732"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.1.133"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb06368.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.1991.9.6.941","article-title":"Effective treatment of small non\u2010cleaved cell lymphoma with high\u2010intensity brief\u2010duration chemotherapy","volume":"9","author":"McMaster ML","year":"1991","journal-title":"J Clin Oncol."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf253"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.3.925"},{"issue":"2","key":"e_1_2_6_19_2","first-page":"33","article-title":"Additional chemotherapy agents improve treatment outcome for children and adults with advanced B\u2010cell lymphomas","volume":"25","author":"Adde M","year":"1998","journal-title":"Semin Oncol."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.10.2471.2471"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.359"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.359"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2184.35.s1.9.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.8.2461"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3370"},{"key":"e_1_2_6_26_2","first-page":"3294","article-title":"Improved treatment results in childhood B\u2010cell neoplasms with tailored intensification of therapy: a report of the Berlin\u2010Frankfurt\u2010Munster Group Trial NHL\u2010BFM 90","volume":"94","author":"Reiter A","year":"1999","journal-title":"Blood."},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900080407"},{"key":"e_1_2_6_28_2","first-page":"151","article-title":"B\u2010cell acute lymphoblastic leukemia (B\u2010ALL): a report of 17 pediatric cases","volume":"77","author":"Rosanda C","year":"1992","journal-title":"Haematologica."}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.20143","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.20143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:42:55Z","timestamp":1760258575000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.20143"}},"subtitle":["Final Results of Cancer and Leukemia Group B Study 9251"],"short-title":[],"issued":{"date-parts":[[2004,3,4]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["10.1002\/cncr.20143"],"URL":"https:\/\/doi.org\/10.1002\/cncr.20143","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,4]]}}}